<DOC>
	<DOCNO>NCT00771316</DOCNO>
	<brief_summary>The purpose study demonstrate MK0826 comparable Meropenem treatment complicate Urinary Tract Infections ( UTIs ) adult .</brief_summary>
	<brief_title>Clinical Trial Study Safety Effectiveness MK0826 Other Antibiotic Therapy Patients With Complicated Urinary Tract Infection ( 0826-054 )</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Urinary Tract Infections</mesh_term>
	<mesh_term>Meropenem</mesh_term>
	<mesh_term>Ertapenem</mesh_term>
	<criteria>Patient clinically suspect /or bacteriologically document complicated UTI acute pyelonephritis judge investigator serious Patient one positive urine culture within 48 hour enrollment Patient one sign symptoms either upper low UTI Patient male without bladder catheter urologic abnormality ; OR patient female history clinical evidence one urologic abnormalities Patient receive amount effective concomitant antibiotic therapy obtain urine culture admission study ( admission urine culture ) prior administration first dose study antibiotic Patient 's infection treat great 24 hour systemic antibiotic therapy know effective presume documented pathogen within 72 hour period immediately prior consideration entry study Patient complete obstruction portion urinary tract . Patient history seizure uncomplicated febrile seizure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>